3i invests in newly-formed ten23 to build biologics-focused CDMO

Using the playbook that guided 3i's formation of bioprocessing platform SaniSure, the firm believes the best way to achieve its latest vision is by building it.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this